4lva
From Proteopedia
(Difference between revisions)
| (5 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==Fragment-based Identification of Amides Derived From trans-2-(Pyridin-3-yl)cyclopropanecarboxylic Acid as Potent Inhibitors of Human Nicotinamide Phosphoribosyltransferase (NAMPT)== | |
| + | <StructureSection load='4lva' size='340' side='right'caption='[[4lva]], [[Resolution|resolution]] 1.55Å' scene=''> | ||
| + | == Structural highlights == | ||
| + | <table><tr><td colspan='2'>[[4lva]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4LVA OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4LVA FirstGlance]. <br> | ||
| + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.55Å</td></tr> | ||
| + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=20M:N-(4-{[4-(PYRROLIDIN-1-YL)PIPERIDIN-1-YL]SULFONYL}BENZYL)-2H-PYRIDO[4,3-E][1,2,4]THIADIAZIN-3-AMINE+1,1-DIOXIDE'>20M</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=PO4:PHOSPHATE+ION'>PO4</scene></td></tr> | ||
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4lva FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4lva OCA], [https://pdbe.org/4lva PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4lva RCSB], [https://www.ebi.ac.uk/pdbsum/4lva PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4lva ProSAT]</span></td></tr> | ||
| + | </table> | ||
| + | == Function == | ||
| + | [https://www.uniprot.org/uniprot/NAMPT_HUMAN NAMPT_HUMAN] Catalyzes the condensation of nicotinamide with 5-phosphoribosyl-1-pyrophosphate to yield nicotinamide mononucleotide, an intermediate in the biosynthesis of NAD. It is the rate limiting component in the mammalian NAD biosynthesis pathway (By similarity). | ||
| - | + | ==See Also== | |
| - | + | *[[Phosphoribosyltransferase 3D structures|Phosphoribosyltransferase 3D structures]] | |
| - | + | __TOC__ | |
| + | </StructureSection> | ||
| + | [[Category: Homo sapiens]] | ||
| + | [[Category: Large Structures]] | ||
| + | [[Category: Bravo B]] | ||
| + | [[Category: Dragovich PS]] | ||
| + | [[Category: Feng Y]] | ||
| + | [[Category: Giannetti AM]] | ||
| + | [[Category: Gunzner-Toste J]] | ||
| + | [[Category: Ho Y]] | ||
| + | [[Category: Hua R]] | ||
| + | [[Category: Liederer BM]] | ||
| + | [[Category: Liu Y]] | ||
| + | [[Category: O'Brien T]] | ||
| + | [[Category: Oeh J]] | ||
| + | [[Category: Sampath D]] | ||
| + | [[Category: Shen Y]] | ||
| + | [[Category: Skelton N]] | ||
| + | [[Category: Wang C]] | ||
| + | [[Category: Wang L]] | ||
| + | [[Category: Wang W]] | ||
| + | [[Category: Wu H]] | ||
| + | [[Category: Xiao Y]] | ||
| + | [[Category: Yuen P]] | ||
| + | [[Category: Zak M]] | ||
| + | [[Category: Zhao G]] | ||
| + | [[Category: Zhao Q]] | ||
| + | [[Category: Zheng X]] | ||
Current revision
Fragment-based Identification of Amides Derived From trans-2-(Pyridin-3-yl)cyclopropanecarboxylic Acid as Potent Inhibitors of Human Nicotinamide Phosphoribosyltransferase (NAMPT)
| |||||||||||
Categories: Homo sapiens | Large Structures | Bravo B | Dragovich PS | Feng Y | Giannetti AM | Gunzner-Toste J | Ho Y | Hua R | Liederer BM | Liu Y | O'Brien T | Oeh J | Sampath D | Shen Y | Skelton N | Wang C | Wang L | Wang W | Wu H | Xiao Y | Yuen P | Zak M | Zhao G | Zhao Q | Zheng X
